Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xian-Lu Song

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Asian Journal of Andrology|December 23, 2017
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasionYao-An Wen, Bo-Wei Zhou, Dao-Jun Lv, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|September 22, 2005
[Effect of Guliu capsule combined with 89Sr therapy on metastatic bone tumor]Xu-chun Su, Yong-lin Wang, Xue-yan Yang, et al.
Asian Journal of Andrology|March 5, 2014
Association between FOXO3A gene polymorphisms and human longevity: a meta-analysisJi-Ming Bao, Xian-Lu Song, Ying-Qia Hong, et al.
Cancer Biology & Therapy|December 9, 2014
ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinomaYa-Jing Zhuang, Zhi-Wei Liao, Hong-Wei Yu, et al.
Theranostics|August 15, 2019
HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling PathwayDao-Jun Lv, Xian-Lu Song, Bin Huang, et al.
Research (Washington, D.C.)|August 1, 2025
New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to ClinicMaoping Cai, Fengtao Zheng, Yang-Zi Ren, et al.
Cancer Gene Therapy|February 17, 2026
The FOSB-IGFBP5-IGF-1 axis: a novel regulatory pathway that suppresses prostate cancer growthJun Huang, Sheng-Dong Ge, Ling-Lan Zhao, et al.
Journal of Translational Medicine|February 16, 2022
Identification of UAP1L1 as a critical factor for prostate cancer and underlying molecular mechanism in tumorigenicityXing-Cheng Wu, Yu-Zhong Yu, Yu-Zhi Zuo, et al.
Journal of Translational Medicine|June 1, 2012
High expression of p300 is linked to aggressive features and poor prognosis of nasopharyngeal carcinomaZhi-Wei Liao, Tong-Chong Zhou, Xiao-Jun Tan, et al.
Molecular Cancer|August 31, 2022
CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signalingTao Xie, Du-Jiang Fu, Zhi-Min Li, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Asian Journal of Andrology|December 23, 2017
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasionYao-An Wen, Bo-Wei Zhou, Dao-Jun Lv, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|September 22, 2005
[Effect of Guliu capsule combined with 89Sr therapy on metastatic bone tumor]Xu-chun Su, Yong-lin Wang, Xue-yan Yang, et al.
Asian Journal of Andrology|March 5, 2014
Association between FOXO3A gene polymorphisms and human longevity: a meta-analysisJi-Ming Bao, Xian-Lu Song, Ying-Qia Hong, et al.
Cancer Biology & Therapy|December 9, 2014
ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinomaYa-Jing Zhuang, Zhi-Wei Liao, Hong-Wei Yu, et al.
Theranostics|August 15, 2019
HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling PathwayDao-Jun Lv, Xian-Lu Song, Bin Huang, et al.
Research (Washington, D.C.)|August 1, 2025
New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to ClinicMaoping Cai, Fengtao Zheng, Yang-Zi Ren, et al.
Cancer Gene Therapy|February 17, 2026
The FOSB-IGFBP5-IGF-1 axis: a novel regulatory pathway that suppresses prostate cancer growthJun Huang, Sheng-Dong Ge, Ling-Lan Zhao, et al.
Journal of Translational Medicine|February 16, 2022
Identification of UAP1L1 as a critical factor for prostate cancer and underlying molecular mechanism in tumorigenicityXing-Cheng Wu, Yu-Zhong Yu, Yu-Zhi Zuo, et al.
Journal of Translational Medicine|June 1, 2012
High expression of p300 is linked to aggressive features and poor prognosis of nasopharyngeal carcinomaZhi-Wei Liao, Tong-Chong Zhou, Xiao-Jun Tan, et al.
Molecular Cancer|August 31, 2022
CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signalingTao Xie, Du-Jiang Fu, Zhi-Min Li, et al.
Pageof 3